Pharmacotherapy of Anxiety Disorders: Current Treatment

Afreen Ayesha

Anxiety disorders are the most common mental problems and a main source of handicap. While there keeps on being sweeping examination in posttraumatic stress problem (PTSD), misery and schizophrenia, there is a general shortage of novel meds being scrutinized for tension issues. This current audit's first point is to sum up flow pharmacological medicines (both endorsed and off-mark) for alarm issue (PD), summed up nervousness problem (GAD), social tension issue (SAD), and explicit fears (SP), including specific serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitors (SNRIs), azapirones (e.g., buspirone), blended antidepressants (e.g., mirtazapine), antipsychotics, antihistamines (e.g., hydroxyzine), alpha and beta-adrenergic meds (e.g., propranolol, clonidine), and GABAergic prescriptions (benzodiazepines, pregabalin, and gabapentin).